Advanced glycation end product associated skin autofluorescence: a mirror of vascular function?

Exp Gerontol. 2013 Jan;48(1):38-44. doi: 10.1016/j.exger.2012.04.011. Epub 2012 May 12.

Abstract

Advanced glycation end products (AGEs) seem to be involved in aging as well as in the development of cardiovascular diseases. During aging, AGEs accumulate in extracellular matrix proteins like collagen and contribute to vessel stiffness. Whether non-invasive measurement of AGE accumulation in the skin may reflect vessel function and vessel protein modification is unknown. Herein we set out to analyze the AGE-modifications in the collagens extracted from residual bypass graft material, the skin autofluorescence reflecting the accumulation of AGEs in the body as well as the pulse wave velocity reflecting vessel stiffness. Collagen types I and III (pepsin digestible collagen fraction) were isolated from the veins of 52 patients by proteolysis. The residual collagen fraction was further extracted by collagenase digestion. Collagen was quantified by hydroxyproline assay and AGEs by the AGE intrinsic fluorescence. Skin autofluorescence was measured with an autofluorescence reader; pulse wave velocity with the VICORDER. The collagen AGE autofluorescence in patient vein graft material increased with patient age. The pepsin digestible collagen fraction was significantly less modified in comparison to the collagenase digestible fraction. Decreasing amounts of extracted collagenase digestible collagen correspond with increasing AGE autofluorescence. Skin autofluorescence and vessel stiffness were significantly linked to the AGE autofluorescence of the collagenase digestible collagen fraction from graft material. In conclusion we have found that skin autofluorescence and pulse wave velocity as non-invasive parameters significantly correlate with the AGE contained in graft material and therefore are strong predictors of vessel AGE modifications in patients with coronary heart disease. Whether the analysis of the skin autofluorescence leads to an improvement of the risk stratification in patients suffering from cardiovascular disease has to be further tested.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aging / metabolism
  • Aging / physiology
  • Blood Flow Velocity / physiology
  • Blood Glucose / metabolism
  • Body Mass Index
  • Carotid Artery, Common / physiopathology
  • Collagen Type I / metabolism
  • Collagen Type III / metabolism
  • Coronary Disease / metabolism*
  • Coronary Disease / physiopathology
  • Diabetes Mellitus, Type 2 / metabolism
  • Femoral Artery / physiopathology
  • Fluorescence
  • Glycated Hemoglobin / metabolism
  • Glycation End Products, Advanced / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Saphenous Vein / metabolism
  • Saphenous Vein / transplantation
  • Skin / blood supply*
  • Skin / metabolism
  • Smoking / metabolism
  • Vascular Stiffness / physiology

Substances

  • Blood Glucose
  • Collagen Type I
  • Collagen Type III
  • Glycated Hemoglobin A
  • Glycation End Products, Advanced
  • hemoglobin A1c protein, human